Login | Register

Diabetes Drug Pioglitazone Associated With Bladder Cancer Risk

According to a study published in British Medical Journal (BMJ), a drug for treating type 2 diabetes called Pioglitazone is linked to a higher risk of bladder cancer and taking the drug continuously for longer than two years doubles the risk. The researchers stress, however, that the risk in absolute terms is relatively low with up to 137 extra cases per 100,000 person years...

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *